1 | board of clinical advisors | | | | | | | 4 | 0.89% |
2 | its board of clinical | | | | | | | 3 | 0.67% |
3 | software for the diagnostic | | | | | | | 3 | 0.67% |
4 | – neuropacstm a leading | | | | | | | 3 | 0.67% |
5 | for the launch of | | | | | | | 3 | 0.67% |
6 | neuropacstm a leading innovator | | | | | | | 2 | 0.45% |
7 | fl – neuropacstm a | | | | | | | 2 | 0.45% |
8 | gainesville fl – neuropacstm | | | | | | | 2 | 0.45% |
9 | of parkinson’s disease gainesville | | | | | | | 2 | 0.45% |
10 | diagnostic of parkinson’s disease | | | | | | | 2 | 0.45% |
11 | the diagnostic of parkinson’s | | | | | | | 2 | 0.45% |
12 | for the diagnostic of | | | | | | | 2 | 0.45% |
13 | innovative software for the | | | | | | | 2 | 0.45% |
14 | leading innovator in aidriven | | | | | | | 2 | 0.45% |
15 | launch of its innovative | | | | | | | 2 | 0.45% |
16 | the launch of its | | | | | | | 2 | 0.45% |
17 | advisors company retains an | | | | | | | 2 | 0.45% |
18 | clinical advisors company retains | | | | | | | 2 | 0.45% |
19 | of clinical advisors company | | | | | | | 2 | 0.45% |
20 | on its board of | | | | | | | 2 | 0.45% |
21 | news neuropacs enrolls dr | | | | | | | 2 | 0.45% |
22 | a leading innovator in | | | | | | | 2 | 0.45% |
23 | parkinson’s disease gainesville fl | | | | | | | 2 | 0.45% |
24 | innovator in aidriven neurological | | | | | | | 2 | 0.45% |
25 | neurological diagnostics today … | | | | | | | 2 | 0.45% |
26 | radiology and neurology by | | | | | | | 2 | 0.45% |
27 | diagnostics today … news | | | | | | | 2 | 0.45% |
28 | advisors company retains a | | | | | | | 2 | 0.45% |
29 | collaborator for the launch | | | | | | | 2 | 0.45% |
30 | email comment or message | | | | | | 1 | 0.22% |
31 | ceo david vaillancourt foundercso | | | | | | | 1 | 0.22% |
32 | 90 accuracy 1500 mri | | | | | | | 1 | 0.22% |
33 | first last email comment | | | | | | 1 | 0.22% |
34 | last email comment or | | | | | | 1 | 0.22% |
35 | david vaillancourt foundercso angelos | | | | | | | 1 | 0.22% |
36 | some facts about neuropacs? | | | | | | | 1 | 0.22% |
37 | martin handfield ceo david | | | | | | | 1 | 0.22% |
38 | usvideo some facts about | | | | | | | 1 | 0.22% |
39 | about usvideo some facts | | | | | | | 1 | 0.22% |
40 | of your facility learn | | | | | | | 1 | 0.22% |